Professor Kirsten Spann
Faculty of Health,
School of Biomedical Sciences
Biography
Prof. Kirsten Spann is currently the Director of the Centre for Immunology and Infection Control, Faculty of Health, and also head of the Respiratory Virus Research Group. She leads research in the field of respiratory viral infections, that encompasses disease pathogenesis; in particular the interplay between viruses and the immune responses, and virus transmission via aerosols and surface contamination. She graduated with a PhD at the University of Queensland in 1997. She was then a research fellow at CSIRO in the field of aquaculture disease diagnostics and management until 2000, as which time she moved to the USA to take a position as a research scientist at the National Institute of Allergy and Infectious Diseases (NIAID). At NIAID, she was involved in the generation of recombinant vaccine candidates for respiratory syncytial virus (RSV), a common childhood infection. In 2006 she returned to Australia to start her own research group at the Royal Children's Hospital in Brisbane focusing on research pertaining to respiratory viral infections. In 2015, she became an Associate Professor at QUT and has a continuous research and teaching position. In 2018 she was promoted to Professor and continues to lead in both the research and teaching aspects of the School of Biomedical Science and Faculty of Health.Personal details
Positions
- Professor
Faculty of Health,
School of Biomedical Sciences
Keywords
Virology, innate immunology, respiratory, paediatric, asthma
Research field
Microbiology, Immunology
Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2020
Qualifications
- PhD (University of Queensland)
- Bachelor of Science with Honours (University of Queensland)
Professional memberships and associations
For more information regarding Professor Kirsten Spann's research profile please open this link to the Infection and Immunity Research Program:https://research.qut.edu.au/infectionandimmunity/
Teaching
Virology Learning progression within the Bachelor of Biomedical Sciences (LS40): First year: LQB292 - contains a module on the basics of virus structure and classification. Second year: LQB494:- contains a module on viral disease pathogenesis and case studies Third year: LQB594: unit co-ordinator,- contains a virology module on molecular diagnostics, vaccine and therapy technology Third year: LQB694:unit coordinator - Infectious disease outbreaks response and preparedness plans.
Additional teaching with the Bachelor of Medical Laboratory Science (LS47) 2015-2019: virology/ molecular biology modules within the following units: LQB281, LQB594, LQB882
HL53 Bachelor of Biomedical Science Honours course coordinator (2018-2019)
Experience
Prof Spann is involved in research collaborations with hospital partners to solve health challenges in paediatric health including asthma and otitis media (chronic ear infections), and also rhinosinusitis and COPD in adults. She is also collaborating with hospitals to understand and reduce respiratory virus transmission via aerosols and surfaces. This includes SARS-CoV-2; the viruses causing COVID-19 and influenza. She has been conducting research and publishing in the field of respiratory virology for over 20 years. She has held 4 NHMRC projects grants, 2 ARC discovery project grants, and several grants from hospital and philanthropic societies.
Publications
QUT ePrints
For more publications by Kirsten, explore their research in QUT ePrints (our digital repository).
Supervision
Supervision topics
- Why do epithelial cells have antigen processing machinery?
- Phase separation and atmospheric water exchange in droplet nuclei
- An airway chip for screening viral infection mediated immune responses
- Metagenomic analysis of bacterial contamination screening pooled platelets
- An airway chip for screening viral infection mediated immune responses
- Spatial localisation of immunoglobulin A in the gastrointestinal tract.
- Understanding the immunological mechanisms that regulate increased susceptibility to respiratory syncytial viral infection after stem cell transplantation